Midostar Midostaurin 25mg Softgel Capsule - Rydapt ₹ 4444 / Box Get Latest Price Product Brochure Composition Midostaurin (25mg) Manufacturer Zydus Healthcare Ltd Packing 4 Capsule In A Strip Usage Acute myeloid leukemia (AML), systemic mastocytosis Strength 25 mg Product Name: Midostar 25mg Softgel Capsule Brand Name: Midostar, Rydapt, Midostaurin Composition: Midostaurin (25mg) Manufacturer/Marketer: Zydus Healthcare Ltd Packaging: To be provided (specify packaging details if available) Treatment: Acute myeloid leukemia (AML), systemic mastocytosis Product Description: Midostar 25mg Softgel Capsule contains Midostaurin, a kinase inhibitor used in the treatment of acute myeloid leukemia (AML) and systemic mastocytosis. It works by targeting specific proteins involved in cancer cell growth, helping to slow or stop the progression of the disease

Hydroxychloroquine 400 Hydroxychloroquine is in a class of drugs called antimalarials and is also an antirheumatic drug. It works by killing the organisms that cause malaria. Hydroxychloroquine may work to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system.

Hydroxychloroquine is in a class of drugs called antimalarials and is also an antirheumatic drug. It works by killing the organisms that cause malaria. Hydroxychloroquine may work to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system.

Apixaban 5 Mg Tablet Original ₹ 199 / Stripe Get Latest Price Product Brochure Strength 5 mg Packaging Size 10*10 Tablets Packaging Type Box Brand Eliquis Manufacturer Dr morepan Shelf life 24 months Usage To treat and prevent blood clots Prescription/ Non Prescription Non Prescription Also gives Pharmaceutical Third Party Manufacturing ELIQUIS 5 TABLET contains Apixaban, which belongs to the group of medicines called Anticoagulants. It is used to prevent blood clots in patients with an irregular heartbeat (atrial fibrillation). These blood clots can dislodge and travel throughout the body, resulting in systemic embolism and stroke. ELIQUIS 5 TABLET also helps in the treatment of blood clots in the legs (deep vein thrombosis) and the veins of the lungs (pulmonary embolism) and in the prevention of their recurrence in either legs or lungs. ELIQUIS 5 TABLET should be taken with caution in patients who have liver or kidney disease. ELIQUIS 5 TABLET is contraindicated in patients who have active bleeding or have a disease that can lead to active bleeding, such as an active ulcer or a recent bleed in the brain.